Update on Spondyloarthropathies

Spondyloarthropathies constitute a cluster of interrelated and overlapping chronic inflammatory rheumatic diseases that includes ankylosing spondylitis (the most typical form of spondyloarthropathy); reactive arthritis; arthritis associated with psoriasis, Crohn disease, and ulcerative colitis; and a form of juvenile chronic arthritis (1-8). Their clinical spectrum is much wider than previously realized, and some additional, less clearly defined types are categorized as undifferentiated spondyloarthritis (9, 10). Clear differentiation among these various forms, especially in their early stages, may not always be possible owing to overlapping clinical features. However, lack of differentiation does not usually affect treatment decisions. The primary pathologic sites include the entheses, which are the site of bony insertion of ligaments and tendon; the sacroiliac joints and the axial skeleton; the limb joints; and some nonarticular structures, such as the gut, skin, eye, and aortic valve (11-18). The entheses are very widespread, and many sites, predominantly in the axial skeleton and the lower extremities, can be symptomatically involved. Thus, the patient can have tenderness at the insertions of plantar fascia and Achilles tendon into the calcaneum, or patellar tendon insertion into the tibial tubercle. Enthesitis most frequently occurs at sites that bear greater physical stress. Therefore, it has been proposed that tissue-specific modulation of immune response toward fibrosis rather than cell lysis at the sites subjected to stress (for example, the axial skeleton, ascending aorta, anterior uveal tract, and apices of the lungs) may explain the tissue distribution of lesions (19). Table 1 shows the characteristic features of spondyloarthropathies. These diseases are not associated with rheumatoid factor, but they show a strong association with HLA-B27, an allele of the major histocompatibility complex. However, this association varies markedly among the different forms of spondyloarthropathies and among ethnic groups (1, 20-25). Table 1. Features of Spondyloarthropathies Table 2 lists the diseases strongly associated with HLA-B27 in white persons. Both men and women are affected, although the disease has an overall male predominance, and familial aggregation may occur. Spondyloarthropathies usually begin in the late teens and early 20s but may also present earlier in childhood or at an older age; they probably account for about 20% of all chronic arthritides seen in pediatric rheumatology (6-10). Juvenile-onset spondyloarthropathies are not covered in this paper. Table 2. Association of Spondyloarthropathies with HLA-B27 in White Persons Spondyloarthropathies are now recognized as being more prevalent than previously thought. The European Spondyloarthropathy Study Group classification criterion is the one most widely used, because it encompasses the wider disease spectrum. This criterion has been validated in various groups, and its sensitivity and specificity generally exceed 85% (Table 3) (26-30). Studies from western Europe indicate that ankylosing spondylitis in its full spectrum is much more common than previously realized, and its overall prevalence may be similar to that of rheumatoid arthritis (Table 4) (31-33). Moreover, the prevalence of spondyloarthropathies as a whole may be approximately twice as high as was thought previously; this is especially the case in Eskimo and Inuit persons, among whom the prevalence of HLA-B27 is 25% to 40% (1, 21, 27). Conversely, spondyloarthropathies are relatively rare among Japanese persons, who have a very low (<1%) prevalence of HLA-B27 (30). Table 3. The European Spondyloarthropathy Study Group Criteria Table 4. Recent Prevalence Studies of Ankylosing Spondylitis and Related Spondyloarthropathies The undifferentiated forms of spondyloarthropathies, which are frequently underdiagnosed, include isolated clinical syndromes, such as HLA-B27associated seronegative oligoarthritis or polyarthritis, mostly of the lower extremities. This arthritis has no recognizable preceding bacterial infectious trigger, extraarticular clinical features, or associated inflammatory bowel disease or psoriasis (1-3, 8-10). Patients with undifferentiated spondyloarthropathy may have dactylitis (sausage digits) and enthesitis, especially at the heel (Achilles tendonitis and plantar fasciitis) (10). Others may present with an episode of acute anterior uveitis (acute iritis) or have a syndrome of aortic incompetence plus heart block (1-3, 34-39). This cardiac syndrome and acute anterior uveitis may occur in patients with no signs of arthritis or may accompany or precede the onset of spondyloarthropathy. In one Scandinavian study, more than 88% of male patients without arthritis and with aortic incompetence and severe cardiac conduction disturbance were positive for HLA-B27 (39). Approximately 50% of patients with acute anterior uveitis test positive for HLA-B27, and more than half of the HLA-B27positive patients with acute anterior uveitis have some form of spondyloarthropathy (34, 35). Routine HLA-B27 testing is not clinically helpful, because spondyloarthropathies can occur in the absence of the allele. HLA-B27 is present in 8% of healthy white persons, of whom about 90% will never develop these diseases (1-4, 20-22). However, the risk for spondyloarthropathies among HLA-B27positive persons who have a first-degree relative with ankylosing spondylitis is increased threefold (30% instead of 10%). No preventive or curative therapy is available that would justify testing unaffected or asymptomatic relatives for HLA-B27 status (1-3). Ankylosing Spondylitis Ankylosing spondylitis is thought to be the most common and most typical form of spondyloarthropathy. It is two to three times more common in men than women. Ankylosing spondylitis usually begins with back pain and stiffness in adolescence and early adulthood, but diverse presentations may antedate back symptoms in some patients (1-4, 40). It is very rare for ankylosing spondylitis to first begin after 45 years of age, but disease is diagnosed at an older age in many patients, in part because symptoms over the years have been minimal (8-10, 41). The diagnosis of ankylosing spondylitis is clinical, but the classic features suggestive of chronic inflammatory back paininsidious onset before 45 years of age, worsening with inactivity, and improvement with physical exercise (Table 3)are on their own not very specific (42). A history of acute anterior uveitis, a positive family history of ankylosing spondylitis or related spondyloarthropathies, or impaired spinal mobility or chest expansion further supports the clinical diagnosis (1-3, 26, 35, 40, 43). Other clinical indicators are the presence of enthesitis, with resultant tenderness over the sacroiliac joints and the spine and sometimes at other sites, such as the heels, iliac crest, and anterior chest wall (26, 44, 45). The modified New York criteria for ankylosing spondylitis are now commonly used for disease classification (Table 5) (46). Table 5. The Modified New York Criteria for Ankylosing Spondylitis The clinical diagnosis is supported by radiologic evidence of sacroiliitis, which is still considered to be the radiographic hallmark of ankylosing spondylitis. Anteroposterior radiography of the pelvis is usually sufficient. However, in patients in whom clinical suspicion of early disease is high but standard radiography of the sacroiliac joints is normal or shows only equivocal changes, magnetic resonance imaging, especially with gadolinium enhancement, produces excellent radiation-free evidence of sacroiliitis and enthesitis (17, 47, 48). Magnetic resonance imaging is especially valuable in identifying sacroiliitis in children and adolescents (6, 48). However, the test is expensive. The diagnosis is usually delayed by 5 to 6 years, especially in patients with an early or incomplete clinical picture (8, 9, 49-51). Multiple referrals of such patients for the same symptoms often do not yield a correct diagnosis, and during this prolonged diagnostic delay, many unnecessary and invasive investigations are performed (49). In a comparison study, ankylosing spondylitis was more frequently detected in a specialized clinic than in a community setting (50). A normal erythrocyte sedimentation rate does not exclude active disease (52). Some patients may have mild constitutional symptoms, such as malaise, loss of appetite, or mild fever, in the early stage of the disease. One or more episodes of acute anterior uveitis (acute iritis or iridocyclitis) are a prominent extraarticular feature of ankylosing spondylitis, occurring in 25% to 40% of patients; these episodes are less common among persons lacking HLA-B27 (1-4, 53). Painful, inflamed, or gritty eye, with or without blurring of vision, needs urgent ophthalmologic examination to exclude acute anterior uveitis (34). This disorder is typically unilateral and tends to recur, sometimes in the contralateral eye. Other, uncommon extraarticular features are aortic incompetence and associated cardiac conduction disturbances or heart block (36-39). Spinal osteoporosis is frequently observed, especially in patients with severe ankylosing spondylitis of long duration. Spinal osteoporosis occurs in part because of ankylosis and lack of mobility, but it can also occur in a relatively early stage of the disease, perhaps as a result of proinflammatory cytokines (54-56). Assessment of biochemical markers of bone metabolism has shown that diminished bone formation and enhanced bone resorption are involved (55). Osteoporosis may contribute to spinal fractures and progressive spinal deformity. Patients with ankylosed spine, especially when the ankylosis also involves the neck, are prone to spinal fractures that can happen even after trivial trauma and are easily overlooked (57-60). Transverse displaced fractures, especially of the neck, can result in quadriplegia or para

[1]  M. Dougados,et al.  Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. , 1999, The Journal of rheumatology.

[2]  B. Amor Reiter's syndrome. Diagnosis and clinical features. , 1998, Rheumatic diseases clinics of North America.

[3]  L. D. de Witte,et al.  Continuation of group physical therapy is necessary in ankylosing spondylitis: results of a randomized controlled trial. , 1994, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[4]  A Calin,et al.  HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. , 1996, Annals of the rheumatic diseases.

[5]  A. Bowcock,et al.  The genetics of psoriasis: a complex disorder of the skin and immune system. , 1998, Human molecular genetics.

[6]  D. Wakefield,et al.  Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. , 1999, Arthritis and rheumatism.

[7]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[8]  S. van der Linden,et al.  Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial. , 1994, The Journal of rheumatology.

[9]  J. Braun,et al.  Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. , 2000, Arthritis and rheumatism.

[10]  P. Njobvu,et al.  Psoriatic arthritis and human immunodeficiency virus infection in Zambia. , 2000, The Journal of rheumatology.

[11]  T. Castelló,et al.  Traumatic spinal cord injury complicating ankylosing spondylitis , 1998, Spinal Cord.

[12]  P Wordsworth,et al.  Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.

[13]  H. Zeidler,et al.  Undifferentiated spondyloarthropathies. , 1992, Rheumatic diseases clinics of North America.

[14]  P. Bowness,et al.  Jekyll and Hyde: the transformation of HLA-B27. , 2000, Immunology today.

[15]  C Wilson,et al.  HLA molecules, bacteria and autoimmunity. , 2000, Journal of medical microbiology.

[16]  E. Märker-Hermann,et al.  CD4+ and CD8+ clonal T cell expansions indicate a role of antigens inankylosing spondylitis; a study in HLA‐B27+ monozygotic twins , 2001, Clinical and experimental immunology.

[17]  Aneurysmal dilatation of ascending aorta and aortic insufficiency in juvenile spondyloarthropathy. , 1997, Scandinavian journal of rheumatology.

[18]  J. Braun,et al.  Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides , 2001, Current opinion in rheumatology.

[19]  S. Jalkanen,et al.  Human Leukocyte Subpopulations from Inflamed Gut Bind to Joint Vasculature Using Distinct Sets of Adhesion Molecules1 , 2001, The Journal of Immunology.

[20]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[21]  M. Dougados,et al.  The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. , 2000, Arthritis and rheumatism.

[22]  J. Jover,et al.  Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. , 2000, The Journal of rheumatology.

[23]  G. Jhangri,et al.  A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. , 2002, Arthritis and rheumatism.

[24]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[25]  O. Oniankitan,et al.  Spondyloarthropathies in sub-Saharan Africa , 2000, Current Opinion in Rheumatology.

[26]  S. M. van der Linden,et al.  A wider spectrum of spondyloarthropathies. , 1990, Seminars in arthritis and rheumatism.

[27]  R. Colbert HLA-B27 misfolding and spondyloarthropathies: not so groovy after all? , 2000, The Journal of rheumatology.

[28]  John C. Davis,et al.  Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. , 2002, The New England journal of medicine.

[29]  A. Silman,et al.  The aetiology of psoriatic arthritis. , 2001, Rheumatology.

[30]  G. Jhangri,et al.  Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. , 2001, The Journal of rheumatology.

[31]  J. Braun,et al.  Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. , 1998, Arthritis and rheumatism.

[32]  H. Zeidler,et al.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.

[33]  H. Luthra,et al.  HLA-B27 and other predisposing factors in spondyloarthropathies. , 1998, Current opinion in rheumatology.

[34]  M. Khan,et al.  HLA-B27 and its subtypes in world populations. , 1995, Current opinion in rheumatology.

[35]  A. Collins,et al.  The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. , 2000, Rheumatology.

[36]  C. Goldsmith,et al.  The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial. , 1990, The Journal of rheumatology.

[37]  E. Bywaters,et al.  Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. , 2000, Arthritis and rheumatism.

[38]  G. Alarcón,et al.  Evaluation of patients with back pain of suspected inflammatory nature. , 1988, The American journal of medicine.

[39]  A. Bengtsson,et al.  Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. , 1990, BMJ.

[40]  M. Khan,et al.  HLA-B27 polymorphism and association with disease. , 2000, The Journal of rheumatology.

[41]  J. Finkelstein,et al.  Occult vertebral fractures in ankylosing spondylitis , 1999, Spinal Cord.

[42]  M. Minami,et al.  Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. , 2001, The Journal of rheumatology.

[43]  T. Yli-Kerttula,et al.  Effect of antimicrobial treatment on chronic reactive arthritis. , 1993, Clinical and experimental rheumatology.

[44]  M. De Vos,et al.  Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. , 2000, The Journal of rheumatology.

[45]  N. Mehra,et al.  HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. , 2000, Human immunology.

[46]  J. Gran,et al.  Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. , 1985, Annals of the rheumatic diseases.

[47]  G. Lathrop,et al.  Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. , 1992, Arthritis and rheumatism.

[48]  I. Olivieri,et al.  The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. , 2002, Arthritis and rheumatism.

[49]  D. Baeten,et al.  Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. , 2002, Arthritis and rheumatism.

[50]  R. Lawrence,et al.  A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? , 1997, Archives of internal medicine.

[51]  A. Al-Arfaj Profile of Reiter's disease in Saudi Arabia. , 2001, Clinical and experimental rheumatology.

[52]  I. Alvarez,et al.  HLA-B27 and immunogenetics of spondyloarthropathies. , 2000, Current opinion in rheumatology.

[53]  J. Harley,et al.  A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Cats,et al.  Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. , 1985, Arthritis and rheumatism.

[55]  F. Hiepe,et al.  No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. , 1999, Arthritis and rheumatism.

[56]  A. Fleischer,et al.  Thalidomide: current and potential clinical applications. , 2000, The American journal of medicine.

[57]  J. Braun,et al.  Radiologic diagnosis and pathology of the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.

[58]  J. Richert,et al.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. , 2001, Arthritis and rheumatism.

[59]  A. Clarke,et al.  The role of passive stretching in the treatment of ankylosing spondylitis. , 1987, British journal of rheumatology.

[60]  S Kunmartini,et al.  HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. , 1997, The Journal of rheumatology.

[61]  P. Tugwell,et al.  Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis. , 1988, The Journal of rheumatology.

[62]  Y. Konttinen,et al.  Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritis. , 2000, The Journal of rheumatology.

[63]  E. Märker-Hermann,et al.  Psoriatic arthritis: clinical aspects, genetics, and the role of T cells. , 2001, Current opinion in rheumatology.

[64]  A. Poole The histopathology of ankylosing spondylitis: are there unifying hypotheses? , 1998, The American journal of the medical sciences.

[65]  M. Benjamin,et al.  The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites , 2001, Journal of anatomy.

[66]  M. Smith Bacillus Calmette-Guérin induced reactive arthritis. , 2000, The Journal of rheumatology.

[67]  B Hamm,et al.  Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging , 2000, Annals of the rheumatic diseases.

[68]  M. Dougados,et al.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. , 1999, The Journal of rheumatology.

[69]  I. Olivieri,et al.  Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset , 2001, Current opinion in rheumatology.

[70]  E. Ball,et al.  HLA-B27 polymorphism. , 2001, Joint, bone, spine : revue du rhumatisme.

[71]  H. Alaranta,et al.  Traumatic spinal cord injury as a complication to ankylosing spondylitis. An extended report. , 2002, Clinical and experimental rheumatology.

[72]  M. Leirisalo-Repo,et al.  Chlamydia pneumoniae as a triggering infection in reactive arthritis. , 1999, Rheumatology.

[73]  R. Winchester,et al.  Psoriatic arthritis and the spectrum of syndromes related to the SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. , 1999, Current opinion in rheumatology.

[74]  R D Sturrock,et al.  Ankylosing spondylitis and HL-A 27. , 1973, Lancet.

[75]  R. Hammer,et al.  Inflammatory disease in HLA‐B27 transgenic rats , 1999, Immunological reviews.

[76]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.

[77]  L. Laloux,et al.  Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis , 2001, Annals of the rheumatic diseases.

[78]  J. Jover,et al.  Eye involvement in the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.

[79]  M. Dougados,et al.  Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis. , 1999, Arthritis and rheumatism.

[80]  M. Khan,et al.  Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. , 1982, Annals of internal medicine.

[81]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[82]  P. Saikku,et al.  Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. , 1991, Arthritis and rheumatism.

[83]  W. Maksymowych Ankylosing spondylitis--at the interface of bone and cartilage. , 2000, The Journal of rheumatology.

[84]  D. Weeks,et al.  Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. , 2001, American journal of human genetics.

[85]  J. Whittum-Hudson,et al.  Chlamydia and associated arthritis , 2000, Current opinion in rheumatology.

[86]  D. Heijde,et al.  ANKYLOSING SPONDYLITIS: Clinical Features , 1998 .

[87]  B. Kidd,et al.  Delay in diagnosis of spondarthritis. , 1988, British journal of rheumatology.

[88]  F. Pons,et al.  Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. , 1999, Arthritis and rheumatism.

[89]  J. Braun,et al.  Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. , 2002, Arthritis and rheumatism.

[90]  A. Escudero,et al.  Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. , 2000, Joint, bone, spine : revue du rhumatisme.

[91]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[92]  A. Silman,et al.  Genetic studies of psoriatic arthritis: dissecting joints and skin. , 2001, The Journal of rheumatology.

[93]  L. Latulippe,et al.  [Reactive arthritis]. , 1980, L'union medicale du Canada.

[94]  R. Lawrence,et al.  Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. , 1999, The Journal of rheumatology.

[95]  M. Khan,et al.  Scientific contributions of ankylosing spondylitis patient advocacy groups. , 2000, Current opinion in rheumatology.

[96]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.

[97]  P. Emery,et al.  Enthesitis in spondyloarthropathy. , 1999, Current opinion in rheumatology.

[98]  K. Lorig,et al.  Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. , 1993, Arthritis and rheumatism.

[99]  R. Hällgren,et al.  Magnetic resonance imaging of sacroiliac joint inflammation. , 1990, Arthritis and rheumatism.

[100]  R. Porcher,et al.  The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families , 2002, Annals of the rheumatic diseases.

[101]  H. Lindsley,et al.  Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy. , 1999, The Journal of rheumatology.

[102]  Andre Peeters,et al.  Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .

[103]  M. Fiorillo,et al.  CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. , 2000, The Journal of clinical investigation.

[104]  R. Queiró,et al.  Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study , 2000, Clinical Rheumatology.

[105]  J. Reveille,et al.  HLA-B27 and genetic predisposing factors in spondyloarthropathies , 2001, Current opinion in rheumatology.

[106]  D. M. van der Heijde,et al.  Ankylosing spondylitis. Clinical features. , 1998, Rheumatic diseases clinics of North America.

[107]  K. Minden,et al.  Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. , 1998, The Journal of rheumatology.

[108]  D. Resnick,et al.  Focal Spinal Abnormalities on Bone Scans in Ankylosing Spondylitis: A Clue to the Presence of Fracture or Pseudarthrosis , 1981, Clinical nuclear medicine.

[109]  R. Hughes,et al.  Reiter's syndrome and reactive arthritis: a current view. , 1994, Seminars in arthritis and rheumatism.

[110]  Audrey M. Nelson,et al.  Textbook of Pediatric Rheumatology , 1990 .

[111]  J. Albar,et al.  HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. , 1997, Tissue antigens.

[112]  T. Sheeran,et al.  Chest pain--a common feature of ankylosing spondylitis. , 1988, Postgraduate medical journal.

[113]  F. Guillemin,et al.  Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest. , 1999, The Journal of rheumatology.

[114]  V. Wright,et al.  ASSOCIATIONS BETWEEN ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, REITER'S DISEASE, THE INTESTINAL ARTHROPATHIES, AND BEHCET'S SYNDROME , 1974, Medicine.

[115]  R. Himstedt On the diagnosis of ankylosing spondylitis. , 1952, Rheumatism.

[116]  W. Braun,et al.  Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. , 1977, Arthritis and rheumatism.

[117]  P. Mease,et al.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.

[118]  J. Teichmann,et al.  Relationship Between Disease Activity and Serum Levels of Vitamin D Metabolites and Parathyroid Hormone in Ankylosing Spondylitis , 2001, Osteoporosis International.

[119]  J. Braun,et al.  Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response? , 2000, Annals of the rheumatic diseases.

[120]  R. Winchester,et al.  The co-occurrence of Reiter's syndrome and acquired immunodeficiency. , 1987, Annals of internal medicine.

[121]  P. Emery,et al.  Classification of inflammatory arthritis by enthesitis , 1998, The Lancet.

[122]  P. Pratsidou-Gertsi,et al.  Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. A prospective study of 9 cases. , 1998, Scandinavian journal of rheumatology.

[123]  M. Crawford,et al.  Aortic root disease and valve disease associated with ankylosing spondylitis. , 1998, Journal of the American College of Cardiology.

[124]  D. F. Krongard,et al.  Diagnosis of ankylosing spondylitis. , 1996, Radiologic technology.

[125]  F. Mahmoud,et al.  ASSOCIATION OF MHC CLASS I WITH SPONDYLOARTHROPATHIES IN KUWAIT , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[126]  H. Huppertz,et al.  Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis , 2000, Pediatric Cardiology.

[127]  R. Mader Atypical clinical presentation of ankylosing spondylitis. , 1999, Seminars in arthritis and rheumatism.

[128]  L. Bergfeldt HLA-B27-Associated Cardiac Disease , 1997, Annals of Internal Medicine.

[129]  M. Dougados,et al.  Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. , 1999, The Journal of rheumatology.

[130]  M. Duruöz,et al.  Evaluation of the Amor and ESSG classification criteria for spondylarthropathies in a Turkish population. , 1997, Revue du rhumatisme.

[131]  T. Shih,et al.  Spinal Fractures and Pseudoarthrosis Complicating Ankylosing Spondylitis: MRI Manifestation and Clinical Significance , 2001, Journal of computer assisted tomography.

[132]  E. Veys,et al.  New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti–tumor necrosis factor therapy , 2001, Current opinion in rheumatology.

[133]  A. Calin,et al.  Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. , 1997, The Journal of rheumatology.

[134]  E. Märker-Hermann,et al.  The cutting edge of spondylarthropathy research in the millennium. , 2002, Arthritis and rheumatism.

[135]  A. Reiff,et al.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 2000, The New England journal of medicine.